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A B S T R A C T
Background: Pineoblastomas are very rare malignant lesions with a bad prognosis and high mortality during the
ﬁrst ﬁve years from diagnosis.
Report of cases: We present a retrospective review of three patients with histologically conﬁrmed pineoblastomas
consecutively operated on between 1997 and 2015. One of our patients died> 14 years after surgery, and the
other 2 patients are still alive and in good condition without recurrence of the disease> 12 years after surgery.
All of them underwent gross total resection and craniospinal radiotherapy. Individualized scheme of che-
motherapy was administered in two cases. The cornerstones for the surgical resection of pineoblastomas are
reported.
Conclusions: A proper multidisciplinary management of pineoblastomas, which associates gross total micro-
surgical resection of the lesion and an adjuvant therapy determined by our neurooncology team based on ac-
curate craniospinal adjuvant radiotherapy with boost of radiation on the tumoral bed, and when needed, an
adequate but aggressive medulloblastoma-like chemotherapy, may improve the overall survival of these ma-
lignant lesions.
1. Introduction
Pineoblastomas are very rare malignant lesions with a bad prognosis
and high mortality during the ﬁrst ﬁve years from diagnosis [1,2].
Pineal region tumors represent< 1% of all intracranial neoplasms.
PPTs, a group of relatively heterogeneous pineal lesions, comprise
around 14–27% of all pineal region tumors [1]. In 2007, the World
Health Organization (WHO) Classiﬁcation of Central Nervous System
Tumors recognized 3 diﬀerent PPTs: the WHO grade I pineocytoma
(14–30%), the WHO grade II-III PPT with intermediate diﬀerentiation
(20–62%), and the WHO grade IV pineoblastoma (24–50%). This wide
variation in the relative incidence in the published series reﬂects the
overall rarity of these tumors, and the variability in the used grading
and terminology [1,3]. The 2016 WHO Classiﬁcation of Central
Nervous System Tumors did not add any new feature to the previous
classiﬁcation [4].
In this paper we describe our multidisciplinary management (gross
total resection -GTR-, radiotherapy and chemotherapy) of three pine-
oblastomas operated consecutively in Helsinki between 1997 and 2015.
2. Report of cases
Twenty-three PPTs were operated in Helsinki Neurosurgery during
the study period. Three histologically conﬁrmed WHO grade IV pine-
oblastomas were found. Our neuropathologist (OT) re-evaluated the
histological samples and reconﬁrmed the diagnosis in two of them (case
2 and case 3) (Fig. 1). Patient's information was revised in the Finnish
population register in December 2018 to determine their current status.
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In Helsinki Neurosurgery as previously described, almost all pineal
tumors are approached by a supracerebellar infratentorial route or by
an occipital interhemispheric access with the patient in the sitting
praying position [5,6].
Exceptionally, other approaches such as the subtemporal approach,
telovelar approach to the fourth ventricle, or even the anterior inter-
hemispheric approach might be used.
Acute and rapidly progressive concomitant hydrocephalus requires
external ventriculostomy, endoscopic third ventriculostomy, ven-
triculoperitoneal/ventriculoatrial shunt, or direct removal of the pineal
lesion according to the emergency, cytology study of the cerebrospinal
ﬂuid, presence of tumor markers in blood or spinal ﬂuid, and preference
of the surgeon. However, slow progressive hydrocephalus is generally
treated by direct removal of the lesion.
Careful microneurosurgery aiming a gross total resection of the
tumor is performed following some principles developed in our de-
partment (Table 1) [7,8]. When the histological diagnosis is conﬁrmed,
the neurooncology team composed by a neurosurgeon, an oncologist, a
neuropathologist, a radiologist, and a neurologist determine all further
management and complementary treatment. In case of pineal tumors,
we must remark the importance to determine the treatment modality
for these rare and complex lesions, based on the oncological advisory
commission of every neurooncological department.
2.1. Case 1
An eighteen year-old female was referred from the neurological
department in April 2001. Three months prior, she presented occasional
double vision associated with vertigo, vomiting and early morning
headache. The visual accuracy diminished gradually on the left eye. CT
and brain MR revealed a 3.2×2.4×1.8 cm homogeneously enhancing
pineal region lesion with a cystic component associated with hydro-
cephalus (Fig. 2).
A ventriculoperitoneal shunt was initially placed after negative
cerebrospinal ﬂuid cytology study and absence of tumor markers in
blood and spinal ﬂuid. After few days, the patient underwent a supra-
cerebellar infratentorial approach in sitting position with removal of
the tumor in April 2001. During the postoperative course, MRI images
showed still some contrast enhancement at the level of the cerebral
internal veins with high suspicion of residual tumor. In the following
MRI studies after adjuvant therapy, this contrast enhancement dis-
appeared and no evidence of residual tumor was observed since August
2001 (Fig. 2).
Fig. 1. Microphotographs of a surgically treated pineoblastoma (Case 3). A, B.
Hematoxylin and eosin stain with high cellularity, numerous mitotic ﬁgures,
(38 mitosis/10 High Power Fields) and necrosis. Homer Wright and Flexner-
Wintersteiner rosettes (red arrow) and ﬂeurettes (blue arrow) are also seen C.
Ki67 index of 60%. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
Table 1
Microsurgical pearls in the microsurgical management of pineoblastomas.
1. The proper analysis of the preoperative imaging associated to the experience of
the surgeon determines the optimal approach for pineoblastomas. Whether the
tumor consists of a large supratentorial segment extending behind and above the
corpus callosum and the deep venous system, an occipital interhemispheric route
remains as our best approach. In contrast, an infratentorial lesion behind and
below the neurovascular structures of the pineal region generates an optimal
location for the supracerebellar infratentorial approach. Giant lesions might
require a combined use of both approaches in single or diﬀerent stages.
2. Diﬀerent to other malignant tumors such as inﬁltrative gliomas, the preoperative
evaluation of the MRI imaging and the intraoperative observation of malignant
pineoblastomas determine that this aggressive lesion preserve some grade of
diﬀerentiation from the surrounding structures without aggressive microscopic
inﬁltration. This feature may allow a complete surgical resection without damage of
the neurovascular structures. (Fig. 3)
3. A critical stage during the microneurosurgery is closely related with the adherence
of the tumor and the inﬁltration of external layers of the deep venous structures,
particularly the internal cerebral veins. The tumor should be carefully dissected by
water dissection technique, cotton dissection, and using microscissors and bipolar
microforceps. Along our experience, we highly suspect that most of the residual
tumors are those attached to these vessels. (Figs. 2 and 3)
4. When a high-vascularized area is suspected, intraoperative indocyanine green
angiography is used to deﬁne vascular structures.
5. Along the microsurgical removal, an internal decompression with a thumb
regulated suction tube and bipolar or ring microforceps is performed aiming to ﬁnd
and open the posterior wall of the third ventricle.
6. Once medial, lateral, and superior surfaces of the tumor are separated from the
adjacent tissue, under soft but continuous traction –using bipolar microforceps or
ring microforceps- the tumor is separated from its inferior border by using a thumb
regulated aspiration. A continuous irrigation maintains a clean surgical ﬁeld.
7. A microsurgical mirror or an endoscope may be helpful to recognize some residual
tumor, particularly at the inferior border of the ﬁeld.
8. A careful hemostasis with bipolar coagulation, Surgicel® (Ethicon Inc., Johnsons &
Johnson: Switzerland) and Tachosil® (Takeda Austria GmbH: Linz, Austria) is
carried out, and the closure is accomplished under the microscope.
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The histologic diagnosis was grade IV pineoblastoma. The spinal
MRI studies did not determine spinal metastasis, and the patient in-
itiated fractionated craniospinal radiotherapy three weeks after the
surgery based on the high possibility of subtotal resection of the tumor,
and on the relative young age of the patient. However, this treatment
had to be suspended after 2 weeks due to meningitis and the shunt was
removed to start systemic antibiotic therapy. Finally, a protocol of
36 Gy craniospinal radiation with an additional 25 Gy boost of radiation
on the tumoral bed, divided in a daily dose of 1.8 Gy, ﬁnished on
August 3, 2001. Concomitant chemotherapy was not administered due
the history of infection. However, post radiotherapy adjuvant che-
motherapy was based on lomustine (CCNU) and vincristine (VCR)
protocol.
One year after surgery, the patient who clinically presented slowly
progressive hydrocephalus required a deﬁnitive ventriculoperitoneal
shunt, which was revised once more after few weeks.
A two years follow-up brain MRI demonstrated absence of tumor
recurrence. However, the spinal MRI demonstrated a cervicothoracic
syringomyelia and probable arachnoiditis. The patient had walking
diﬃculties and underwent rehabilitation and equine-assisted therapy.
Seven years after surgery, the patient had still walking diﬃculties at the
clinical evaluation.
Nine years after surgery, no residual tumor was found at craniosp-
inal MRI studies. Syringomyelia was stable and smaller compared to the
previous MRI. The patient was paraparetic, but was still able to walk.
In January 2015, fourteen years after surgery, the patient presented
a right side VI cranial nerve paresis and slight facial paresis. The cra-
niospinal MRI revealed important tumoral inﬁltration of the midbrain
and spinal cord. Nonetheless, no recurrence in the pineal region was
observed in July 2015 (Fig. 2). The patient died from pneumonia in
September 2015, 173months after surgery.
2.2. Case 2
A three year-old female was referred from the pediatric department
in November 2004. A month prior, she presented some eye movement
problems, vomiting, and balance diﬃculties. Brain MRI revealed a
2.7×3.1× 2.7 cm homogeneously enhancing pineal region lesion
with a cystic component associated to hydrocephalus (Fig. 3).
A ventriculoperitoneal shunt was initially placed after negative
cerebrospinal ﬂuid cytology study and absence of tumor markers in
blood and spinal ﬂuid. Few days later, the patient underwent a supra-
cerebellar infratentorial approach in sitting position with GTR of the
tumor in December 2004. The postoperative course was uneventful.
The histologic diagnosis was grade IV pineoblastoma. The histologic
study determined six mitoses for 10 High Power Fields, and a Ki-67
labeling index of 70%. Necrotic foci were also seen in the samples.
Six weeks after the surgery, the pediatric patient received adjuvant
chemotherapy and fractionated craniospinal radiotherapy based on an
aggressive medulloblastoma protocol. 36 Gy craniospinal radiation
with an additional 18 Gy boost of radiation on the tumoral bed was
divided in a daily dose of 1.8 Gy. Concurrently, VCR 1.5 mg/m2 once a
week for 6 weeks was set. Six weeks after this initial treatment, a new
scheme of chemotherapy was administrated every 6 weeks with 8 cycles
of CCNN: 75mg/m2×1; cisplatino: 75mg/m2×1; and VCR: 1,5mg/
m2×3 on days 0, 7, and 14.
The last evaluation of the patient was performed in May 2018, and
she did not show any neurological deﬁcit. Brain MRI did not show any
recurrence as well. The patient continues to do well > 170months
following surgery.
2.3. Case 3
A twenty ﬁve year-old female was referred to our department with
Fig. 2. Pre-operative image of a WHO grade IV pineoblastoma (A). B. Post-operative cranial MRI (July 2001) showing some contrast enhancement at the level of the
internal cerebral veins, which disappeared in the following MRI study (C, August 2001). D–F Last craniospinal MRI (July 2015) revealing tumoral inﬁltration of the
midbrain and spinal cord without pineal recurrence.
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deterioration of consciousness and acute hydrocephalus associated with
a pineal region lesion.
The patient underwent immediately a supracerebellar infratentorial
approach in sitting position with GTR of the tumor in April 2006.
During the postoperative course, the patient improved partially her
consciousness state and developed a Parinaud's syndrome. A cranial CT
showed the persistence of hydrocephalus, and an endoscopic third
ventriculostomy was carried out. However, the procedure was in-
suﬃcient and ﬁnally a ventriculoperitoneal shunt was placed.
The histologic diagnosis was grade IV pineoblastoma. The histologic
study determined 38 mitoses for 10 High Power Fields, and a Ki-67
labeling index of 60%. Necrotic foci were also seen in the samples, but
no tumoral activity was found in the cerebrospinal ﬂuid. Six weeks after
the surgery, the patient received adjuvant fractionated craniospinal
radiotherapy. 36 Gy craniospinal radiation with an additional 18 Gy
boost of radiation on the tumoral bed was divided in a daily dose of
1.8 Gy. The neurooncology team did not recommend the administration
of adjuvant chemotherapy based on the age, absence of extra-pineal
tumor activity and gross total resection of the tumor.
The gaze paralysis improved gradually with very occasional double
vision at the last follow-up in October 2017. Brain MRI did not show
any recurrence as well. The patient continues to do well> 152months
following surgery.
3. Discussion
In this paper we describe our multidisciplinary management (GTR,
radiotherapy and chemotherapy) of three pineoblastomas operated in
Helsinki between 1997 and 2015. One of our patients died> 14 years
after surgery, and the other 2 patients are still alive and in good con-
dition without recurrence of the disease> 12 years after surgery. All of
them underwent GTR and craniospinal radiotherapy with boost of ra-
diation on the tumoral bed. Individualized scheme of chemotherapy
was administered in two cases.
3.1. Outcome in pineoblastoma patients
Several studies have reported about the poor outcome of pine-
oblastomas. A median survival of 20months and a 5-year survival rate
of 10% were initially reported [9–11]. In 2007, Nakazato et al. [1]
summarized that median postsurgical survivals of pineoblastomas vary
between 24 and 30months, and the main causes of death are re-
presented by metastases within the central nervous system. The authors
mentioned that the prognosis is aﬀected by the extent of the disease at
the time of diagnosis, which is determined by cerebrospinal ﬂuid and
spine MRI examination, as well as by the extent of resection and
radiotherapy. However, the outcome seems to be better when the tumor
is discovered incidentally.
A literature review conducted by Tate et al. [2] in 2012 about the
long-term postsurgical prognosis of patients with pineoblastomas con-
cluded that they have an overall survival rate of 54% (175 of 299 pa-
tients) at a mean follow-up of 31 ± 1.9months (range, 1–159months).
The analyses demonstrated a markedly worse prognosis for children
aged ≤5 years. The prognosis was inversely proportional to the degree
of resection. Thus, the ﬁve-year survival rate was 84% for GTR, 53% for
subtotal resection, and 29% for debulking. Multivariate analysis in-
dicated that not achieving GTR markedly worsened patient survival,
independently of variables as very young age, intracranial dissemina-
tion, and other combinations of adjuvant therapies. They pointed out
that pediatric and adult pineoblastomas have a diﬀerent behavior and
should be separately considered when analyzing their response to sur-
gical and adjuvant therapy.
Considering pineoblastomas in children, Parikh et al. [12] recently
reported their experience in 41 pediatric and adult pineoblastoma pa-
tients with a median age at diagnosis of 5.5 years (0.4–28.1) and a
median follow-up of 34.5 months (4.7–183.5). All patients except 3
Fig. 3. Pre- (A–C) and post-operative (D, E) MRI images of a WHO grade IV pineoblastoma. F, Last cranial computed tomography study (May 2018).
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were younger than 20 years old. Nineteen patients, (17 younger than
5 years old) experienced tumor relapse with a median progression-free
survival of 11.3 months, and 18 ultimately succumbed to their disease.
Patients who died or experienced treatment failure were younger
(median, 2.69 vs 6.5 years), and had a metastatic disease at diagnosis in
most of the cases. When analyzing only patients 5 years of age or older
with focal disease at presentation, those who had a GTR or near-total
resection had greater overall survival compared to patients who un-
derwent subtotal resection or biopsy (75.18 versus 48.57months), and
no patient died for tumor progression. They concluded that young age,
metastatic disease at presentation, and tumor relapse are associated
with a poor prognosis. Therefore, maximal tumor resection should be
the goal in patients older than 5 years with focal disease.
Regarding radiosurgery as main therapy for pineoblastomas, a study
based on the stereotactic Gamma Knife radiosurgery of histologically
deﬁned tumors, reported an actuarial local control and a survival rate
of 27% and 48% at a 5 years follow up, respectively. In this study, the
authors analyzed 13 patients who underwent a subtotal resection in 7
cases, a biopsy in 5, and a GTR in only one case [13]. These results
contrast with the 80% survival rate and 80% actuarial local control
reported at a 20 years follow up for germinomas, which are the most
radiosentive tumors of the pineal region [13,14].
3.2. Factors associated with better outcome in our series
The general prognosis of pineoblastomas is considered poor and as
mentioned, factors such as minor extent of the disease at the time of
diagnosis, major extent of resection, radiotherapy delivery, tumors
found incidentally, and adult pineoblastomas, are associated with
better outcome. In children, young ages, major extend of the disease at
presentation, and tumor relapse are associated with a poor prognosis.
Most of the authors reported a low rate of GTR, with a diﬃcult
tumor control, frequent recurrences, and a high mortality during the
ﬁrst ﬁve years from diagnosis [1,2,9–12]. Those ﬁndings contrast with
our results, which based on the neurooncology team recommendations
are the following: a) the GTR of the tumor, which we believe is the most
important element aiming to obtain good long-term results, b) adjuvant
craniospinal radiotherapy with boost of radiation on the tumoral bed
and c) individualized aggressive medulloblastoma-like chemotherapy
in children and patients with high risk of metastasis [5–8]. Some of our
microsurgical pearls to achieve GTR without or with minimal compli-
cations are detailed in Table 1.
GTR might be achieved thanks to the combination of variables such
as an essential proper team work (Neurosurgeon, anesthesiologist,
scrub nurse and all involved personnel), adequate principles of posi-
tioning and approach, skillful microneurosurgery based on the principle
“simple, clean and safe”, and not less importantly, the surgical experi-
ence of the Neurosurgeon.
Regarding the case number one, the deﬁnitive diagnosis of the last
lesion as reason of death remains obscure since no autopsy has been
performed. A secondary malignant tumor after radiation therapy might
be also suggested. However, the retrospective analysis of the case
suggests that the postoperative contrast enhancement close to the in-
ternal cerebral veins represented a small residual tumor, which due to
the diﬃculties delivering radiochemotherapy, developed some micro-
scopic seeding in the midbrain and spinal cord with evident further
metastasis after many years.
The small number of patients represents a limitation of our study.
Nevertheless, as these tumors are extremely rare, we consider especially
important to report our long-term ﬁndings in a non-selected series of
patients.
4. Conclusion
A proper multidisciplinary management of pineoblastomas, based
on the GTR of the lesion, accurate craniospinal adjuvant radiotherapy,
and, when needed, an adequate chemotherapy, may improve the
overall survival of these malignant lesions.
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